503A Chain-of-Custody Supply
The Complete Chain-of-Custody Difference for 503A Compounding
Most wholesale peptide API suppliers provide a Certificate of Analysis. What differentiates Replete Rx for 503A compounding pharmacies is the completeness of the documentation chain — tracing every lot from the FDA green-listed raw material supplier through our pharmacy network, quality release, and delivery to your pharmacy's receiving dock. No gaps. No unverified raw material sources. No imported finished product.
Our chain-of-custody package for 503A pharmacy buyers includes: green list supplier qualification records (confirming raw API is from an FDA import alert green list manufacturer), synthesis or compounding batch records, partner facility environmental monitoring data where available, in-process quality control documentation, HPLC purity report (≥99%), mass spectrometry identity confirmation, endotoxin testing per LAL method, residual solvent testing per USP <467>, and cold-chain temperature logs from our facility to your dock. This is the complete documentation picture your QA pharmacist and state board need.
Why does chain-of-custody matter so much for 503A compounding? Because the risk in peptide API sourcing is not just in the finished compound purity — it's in the raw material origin and manufacturing conditions. A peptide with 99% HPLC purity from unverified raw material presents a different documentation profile than the same compound sourced through a documented pharmacy network with FDA green-listed API. Replete Rx is built to close that documentation gap for licensed 503A buyers.
Our 503A pharmacy onboarding process verifies your state pharmacy license, DEA registration, and pharmacist-in-charge credentials within 24–48 hours. Once approved, your account portal provides per-lot CoA access, chain-of-custody document downloads, and inventory management tools designed for compounding pharmacy procurement teams. See our full quality standards or contact our pharmacy team to request a documentation sample package.
- Chain-of-custody from FDA green-listed raw material through our pharmacy network
- Green list supplier qualification records available per lot
- Production documentation from our pharmacy-network partners, including facility records where available
- HPLC purity ≥99% with full chromatogram per lot
- Endotoxin testing (LAL, <10 EU/mg) — USP Chapter <797> compliant
- Residual solvent testing (USP <467>) per lot
- Cold-chain temperature logs from our facility to your dock
- Account portal CoA and chain-of-custody document access